BioSpace News Archive

AlzeCure presents at Stora Aktiedagarna on November 27

AlzeCure Pharma AB announced that the company is participating at Aktiespararna’s event Stora Aktiedagarna i Stockholm on November 27 at 14:20 CET, where CEO Martin Jönsson will present and answer questions about the latest developments and the company’s plans going forward.

November 22, 2023
·
2 min read
BioMidwest

Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances

Brainomix, the AI-powered medtech solutions company, has heralded its continued US expansion with the launch of its full suite of FDA-cleared modules in its Brainomix 360 platform for stroke care.

November 22, 2023
·
5 min read
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023

Burning Rock Biotech Limited announced that it will hold its annual general meeting on December 20, 2023 at 10:00 a.m. at the Company’s Shanghai office at 6/F, Building 10C, Pujiang Smart Plaza, No. 2168 Chenhang Highway, Minhang District, Shanghai.

November 22, 2023
·
3 min read
BioMidwest

Novel MRI Reveals Brain Changes in Long-COVID Patients

People with long COVID exhibit patterns of changes in the brain that are different from fully recovered COVID-19 patients, according to research being presented next week at the annual meeting of the Radiological Society of North America.

November 22, 2023
·
4 min read
Pharm Country

Axsome Therapeutics to Host Solriamfetol Virtual Investor Event on December 7

Axsome Therapeutics, Inc. today announced that it will host a virtual event on December 7 from 8 a.m. - 10 a.m. Eastern Time.

November 22, 2023
·
4 min read
Drug Development

Entrada Therapeutics Announces Updates on ENTR-601-44 in Duchenne Muscular Dystrophy

Entrada Therapeutics, Inc. today announced the completion of dosing for the first and second cohorts of its Phase 1 clinical trial, ENTR-601-44-101.

November 22, 2023
·
7 min read
Pharm Country

Carisma Therapeutics to Participate in Evercore ISI HealthCONx Conference

Carisma Therapeutics Inc. today announced that Steven Kelly , President and Chief Executive Officer, will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29 at 2:35 pm ET.

November 22, 2023
·
3 min read
Deals

Syncona to Acquire Freeline Therapeutics

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that it has entered into a definitive agreement with a newly established portfolio company of Syncona Ltd.

November 22, 2023
·
15 min read
Drug Development

Immutep Announces Site Expansion for INSIGHT-003 Phase I Trial

Immutep Limited today announces that the INSIGHT-003 trial has been expanded to four sites across Germany including the University Clinic of Ruhr Universität Bochum and the Lung Clinic Cologne-Merheim.

November 22, 2023
·
3 min read
Pharm Country

Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Insomnia or AnxietyGrant of Its Newest U.S. Patent Expands Anavex’s Compounds Intellectual Property Portfolio

Anavex Life Sciences Corp. today announced that the United States Patent and Trademark Office (USPTO) granted U.S. Patent No. 11,813,242 entitled “A2-73 AS A THERAPEUTIC FOR INSOMNIA, ANXIETY, AND AGITATION”.

November 22, 2023
·
5 min read